Samara Abdo El Hakim Kadri

Real-world observational study of ocrelizumab and ofatumumab in patients with multiple sclerosis in Brazil

Background: Anti-CD20 therapies are widely used in multiple sclerosis (MS), and real-world data may complement findings from clinical trials. Objective: The objective is to evaluate the effectiveness and safety of ofatumumab and ocrelizumab in patients with MS in a real-world setting. Methods: This was a single-center,...